First Time Loading...

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 27.21 USD -1.27% Market Closed
Updated: May 9, 2024
ARCT
/
Income Statement
/
Research & Development

Arcturus Therapeutics Holdings Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcturus Therapeutics Holdings Inc
Research & Development Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Research & Development
-$192.1m
CAGR 3-Years
-49%
CAGR 5-Years
-62%
CAGR 10-Years
-39%
Abbvie Inc
NYSE:ABBV
Research & Development
-$7B
CAGR 3-Years
-4%
CAGR 5-Years
-6%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Research & Development
-$6.1B
CAGR 3-Years
18%
CAGR 5-Years
-3%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Research & Development
-$5B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Research & Development
-$3.7B
CAGR 3-Years
-26%
CAGR 5-Years
-21%
CAGR 10-Years
-15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Research & Development
-$4.6B
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-17%

See Also

What is Arcturus Therapeutics Holdings Inc's Research & Development?
Research & Development
-192.1m USD

Based on the financial report for Dec 31, 2023, Arcturus Therapeutics Holdings Inc's Research & Development amounts to -192.1m USD.

What is Arcturus Therapeutics Holdings Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-39%

Over the last year, the Research & Development growth was -30%. The average annual Research & Development growth rates for Arcturus Therapeutics Holdings Inc have been -49% over the past three years , -62% over the past five years , and -39% over the past ten years .

ALPHA SPREAD
Join more than 135,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.